Angiography Catheters Market

Market Overview

The global Angiography Catheters Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach USD 4.6 billion by 2033, growing at a CAGR of 6.2% during the forecast period (2025–2033).

 Angiography catheters are used for imaging and diagnosing vascular diseases by injecting contrast media into blood vessels during angiography procedures. Catheter angiography uses a catheter, x-ray imaging guidance and an injection of contrast material to examine blood vessels in key areas of the body for abnormalities such as aneurysms and disease such as atherosclerosis. The catheter is used for diagnosis and treatment in a single procedure. Catheter angiography gives accurate pictures of the blood vessels and helps define treatment options. The increasing prevalence of cardiovascular diseases, advancements in catheter technology, and growing healthcare infrastructure are key drivers of market growth.

Market Dynamics

Market Drivers

Rising Prevalence of Cardiovascular Diseases (CVDs)

The global rise in cardiovascular diseases, including coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), is a major factor contributing to the growth of the angiography catheters market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions. More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age. Rising awareness of cardiovascular conditions, angiography procedures have become important tool in diagnosing and treating CVDs. The growing adoption of diagnostic angiography including coronary angiography and vascular angiography has consequently raised the demand for advanced angiography catheters, which are essential for imaging the blood vessels and detecting blockages or abnormalities.

Furthermore, aging populations globally, especially in developed regions, are at greater risk for CVDs, leading to an increase in diagnostic procedures using angiography catheters.

Technological Advancements, Rising Healthcare Investments, and the Growing Geriatric Population

Technological advancements in design have played a crucial role in the in-angiography catheter market’s expansion. Innovations in catheter construction have improved manoeuvrability and safety during procedures. Additionally, the integration of digital imaging systems like digital subtraction angiography (DSA) and 3D imaging technologies has elevated the accuracy and effectiveness of diagnostic procedures. For instance, the U.S. Food and Drug Administration (FDA) has approved numerous advanced angiography technologies, such as robot-assisted systems and drug-eluting stents, which further drive the adoption of angiography procedures. The market has also benefited from the introduction of more efficient, less invasive catheter designs, resulting in better patient outcomes and higher procedural success rates.

Rising healthcare expenditure is major factor for expanding the angiography catheters market. Governments and healthcare organizations worldwide have substantially increased their investments in diagnostic imaging and cardiovascular disease management. For instance, according to the World Economic Forum, in 2021 alone, global spending on health reached a staggering $9.8 trillion, accounting for 10.3% of global GDP. Yet, over the last decade, life expectancy has stagnated in many countries, including the United States (US), which alone spends over $4 trillion annually on health. This increased funding has been directed towards upgrading diagnostic centers, expanding hospitals, and improving access to advanced medical technologies, including angiography. Countries like China and Germany are similarly investing in healthcare infrastructure, recognizing the need for advanced cardiovascular diagnostics to address the growing burden of CVDs.

The aging population is also significant driver influencing the growth of the angiography catheters market. As the global population continues to age, the incidence of chronic diseases, particularly cardiovascular diseases, is rising. According to the United Nations, the number of individuals aged 60 years or older is expected to more than double from 1 billion in 2020 to 2.1 billion by 2050, with Europe and North America experiencing the largest increases. According to the World Health Organization (WHO) By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, further increasing the demand for diagnostic and interventional procedures that rely on the angiography catheters market.

Market Restraints

Risk of Complications During Angiography Procedures

Angiography remains a cornerstone in the diagnosis and management of cardiovascular diseases, the risk of procedural complications presents a significant restraint to the growth of the angiography catheters market. Although angiography is a widely used diagnostic tool, the risk of complications such as allergic reactions to contrast agents, kidney damage, and vessel injury may limit the procedure’s popularity. One of the main concerns is the risk of allergic reactions to contrast media used during angiography. Iodinated contrast agents, which are essential for visualizing blood vessels, can cause mild to severe allergic reactions in susceptible individuals. According to the American Journal of Roentgenology, adverse reactions to non-ionic iodinated contrast media occur in approximately 3% of patients, with serious reactions occurring in about 0.04% of cases. While relatively rare, these incidents can be life-threatening and often require immediate medical intervention. The potential for adverse effects may deter patients from opting for angiographic procedures, affecting the angiography catheters market’s growth.

Segmental Analysis

The Angiography Catheters Market is segmented by type and end-user. Each segment plays a crucial role in improving diagnostic accuracy and patient outcomes in angiography procedures.

By Type

Coronary Angiography Catheters segment held the largest market share of 39.6% in 2024, driven by the high prevalence of coronary artery diseases and the widespread adoption of coronary angiography for diagnostic and interventional purposes. Coronary angiography remains the standard for diagnosing heart conditions, leading to continued demand for coronary angiography catheters. The peripheral angiography catheters segment is expected to grow at a substantial rate due to the increasing prevalence of peripheral artery disease (PAD), especially among the aging population. As peripheral angiography becomes more common for diagnosing PAD, this segment will experience robust growth. The neuroangiography catheters segment is witnessing rapid growth, fueled by the rising incidence of neurological disorders, such as brain aneurysms and strokes. Advancements in neuroimaging and the increasing need for interventional procedures are contributing to the growing demand for neuroangiography catheters.

By End-User

Hospitals dominate the angiography catheter market, holding a market share of 59.3% in 2024. The demand for angiography procedures in hospitals is substantial, particularly in large medical centers and cardiac hospitals that perform routine diagnostic procedures and interventional treatments.
Ambulatory surgical centers are increasingly adopting angiography procedures for outpatient diagnostics and treatment, which is contributing to the growth of this segment. ASCs are gaining popularity due to their lower cost structure and convenience for patients.
Diagnostic laboratories are expected to see a steady demand for angiography catheters as the need for precise diagnostics grows. The increasing focus on early detection and preventive healthcare is expected to drive the demand for angiographic tests in diagnostic labs.

Regional Analysis

North America

North America holds the largest market share of 39.7% in 2024, primarily driven by the advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and increasing adoption of innovative medical technologies. The U.S. is a major contributor to angiography catheters market growth due to the widespread use of angiography procedures in hospitals and specialized clinics.

Europe

Europe is another key market, with a strong presence in countries like Germany, France, Austria, Bulgaria and the UK, where cardiovascular diseases are prevalent. In 2021, there were 1.1 million transluminal coronary angioplasty procedures in 25 EU countries for which data are available. Croatia reported the highest ratio of angioplasty procedures that year, with 553 procedures per 100 000 inhabitants. The region is expected to experience significant growth due to the aging population and the increasing availability of advanced healthcare solutions.

Asia-Pacific

The Asia-Pacific region is expected to grow at the fastest rate, with a projected CAGR of 7.8% during the forecast period. Factors such as increasing urbanization, rising healthcare spending, and a growing geriatric population in countries like China, Japan, and India are contributing to the growth of this market.

Latin America and Middle East & Africa

Latin America and Middle East & Africa regions are witnessing moderate growth due to the growing healthcare investments and an increasing focus on the treatment of cardiovascular diseases. However, challenges like economic disparities and healthcare access remain.

Recent Development

1. March 2024: Medtronic launched a next-generation coronary angiography catheter with enhanced imaging capabilities and reduced friction for smoother insertion
2. January 2023: Boston Scientific introduced a new line of neuroangiography catheters designed for better access and navigation during stroke interventions
3. October 2023: Terumo Corporation announced the release of an upgraded peripheral angiography catheter featuring a new design for improved contrast flow and enhanced imaging.